- Home
- SSSS vs QTRX Comparison
SSSS vs QTRX Comparison
Compare SSSS & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSSS
- QTRX
- Stock Information
- Founded
- SSSS 2010
- QTRX 2007
- Country
- SSSS United States
- QTRX United States
- Employees
- SSSS N/A
- QTRX N/A
- Industry
- SSSS Finance: Consumer Services
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- SSSS Finance
- QTRX Industrials
- Exchange
- SSSS Nasdaq
- QTRX Nasdaq
- Market Cap
- SSSS 227.8M
- QTRX 241.2M
- IPO Year
- SSSS N/A
- QTRX 2017
- Fundamental
- Price
- SSSS $10.11
- QTRX $5.02
- Analyst Decision
- SSSS Strong Buy
- QTRX Hold
- Analyst Count
- SSSS 4
- QTRX 4
- Target Price
- SSSS $10.13
- QTRX $11.75
- AVG Volume (30 Days)
- SSSS 255.7K
- QTRX 518.6K
- Earning Date
- SSSS 11-04-2025
- QTRX 11-10-2025
- Dividend Yield
- SSSS 9.99%
- QTRX N/A
- EPS Growth
- SSSS N/A
- QTRX N/A
- EPS
- SSSS 2.60
- QTRX N/A
- Revenue
- SSSS $2,354,933.00
- QTRX $125,784,000.00
- Revenue This Year
- SSSS $7,183.09
- QTRX N/A
- Revenue Next Year
- SSSS N/A
- QTRX $37.03
- P/E Ratio
- SSSS $3.84
- QTRX N/A
- Revenue Growth
- SSSS N/A
- QTRX N/A
- 52 Week Low
- SSSS $4.21
- QTRX $4.05
- 52 Week High
- SSSS $10.34
- QTRX $15.67
- Technical
- Relative Strength Index (RSI)
- SSSS 64.20
- QTRX 39.12
- Support Level
- SSSS $9.68
- QTRX $4.93
- Resistance Level
- SSSS $10.23
- QTRX $5.46
- Average True Range (ATR)
- SSSS 0.34
- QTRX 0.30
- MACD
- SSSS 0.10
- QTRX -0.09
- Stochastic Oscillator
- SSSS 83.87
- QTRX 7.17
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.